I did a 2‑hour adaptive trial design mini-course last week, and the tiny habit of jotting the estimand before reading endpoints made our dose‑selection discussion for a Phase II oncology study a lot sharper. If you’ve got a similarly short rec that paid off - maybe a PK/PD refresher that improved dose justification - I’m all ears.
A 1‑hour PK/PD refresher on exposure - response (free Certara webinar) paid off: I started precomputing a steady‑state Ctrough distribution in Excel with a simple one‑compartment model and log‑normal CL, then walking in with “% above target Ctrough” by dose; that one graphic ended a week of hand‑waving in our Phase II dose justification.